222 related articles for article (PubMed ID: 23737137)
1. Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.
Rizzo R; Trentini A; Bortolotti D; Manfrinato MC; Rotola A; Castellazzi M; Melchiorri L; Di Luca D; Dallocchio F; Fainardi E; Bellini T
Mol Cell Biochem; 2013 Sep; 381(1-2):243-55. PubMed ID: 23737137
[TBL] [Abstract][Full Text] [Related]
2. Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.
Selvais C; D'Auria L; Tyteca D; Perrot G; Lemoine P; Troeberg L; Dedieu S; Noël A; Nagase H; Henriet P; Courtoy PJ; Marbaix E; Emonard H
FASEB J; 2011 Aug; 25(8):2770-81. PubMed ID: 21518850
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles.
Fogli S; Neri T; Nuti E; Mattii L; Camodeca C; Rossello A
Pharmacol Rep; 2019 Jun; 71(3):485-490. PubMed ID: 31005034
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression.
Yang HM; Sung JH; Choi YS; Lee HJ; Roh CR; Kim J; Shin M; Song S; Kwon CH; Joh JW; Kim SJ
Cytotherapy; 2012 Jan; 14(1):70-9. PubMed ID: 21954834
[TBL] [Abstract][Full Text] [Related]
5. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis.
Park GM; Lee S; Park B; Kim E; Shin J; Cho K; Ahn K
Biochem Biophys Res Commun; 2004 Jan; 313(3):606-11. PubMed ID: 14697234
[TBL] [Abstract][Full Text] [Related]
6. Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary.
Schwich E; Hò GT; LeMaoult J; Bade-Döding C; Carosella ED; Horn PA; Rebmann V
Front Immunol; 2020; 11():2046. PubMed ID: 32973812
[TBL] [Abstract][Full Text] [Related]
7. Structural Modeling and Molecular Dynamics of the Immune Checkpoint Molecule HLA-G.
Arns T; Antunes DA; Abella JR; Rigo MM; Kavraki LE; Giuliatti S; Donadi EA
Front Immunol; 2020; 11():575076. PubMed ID: 33240264
[TBL] [Abstract][Full Text] [Related]
8. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells.
Taraboletti G; D'Ascenzo S; Borsotti P; Giavazzi R; Pavan A; Dolo V
Am J Pathol; 2002 Feb; 160(2):673-80. PubMed ID: 11839588
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.
McQuibban GA; Gong JH; Wong JP; Wallace JL; Clark-Lewis I; Overall CM
Blood; 2002 Aug; 100(4):1160-7. PubMed ID: 12149192
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis.
Contini P; Negrini S; Murdaca G; Borro M; Puppo F
Clin Exp Immunol; 2018 Aug; 193(2):152-159. PubMed ID: 29660112
[TBL] [Abstract][Full Text] [Related]
11. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
12. Human Vascular Wall Mesenchymal Stromal Cells Contribute to Abdominal Aortic Aneurysm Pathogenesis Through an Impaired Immunomodulatory Activity and Increased Levels of Matrix Metalloproteinase-9.
Ciavarella C; Alviano F; Gallitto E; Ricci F; Buzzi M; Velati C; Stella A; Freyrie A; Pasquinelli G
Circ J; 2015; 79(7):1460-9. PubMed ID: 25854712
[TBL] [Abstract][Full Text] [Related]
13. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.
Egawa N; Koshikawa N; Tomari T; Nabeshima K; Isobe T; Seiki M
J Biol Chem; 2006 Dec; 281(49):37576-85. PubMed ID: 17050542
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase 2 and membrane type 1 matrix metalloproteinase co-regulate axonal outgrowth of mouse retinal ganglion cells.
Gaublomme D; Buyens T; De Groef L; Stakenborg M; Janssens E; Ingvarsen S; Porse A; Behrendt N; Moons L
J Neurochem; 2014 Jun; 129(6):966-79. PubMed ID: 24611815
[TBL] [Abstract][Full Text] [Related]
15. Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics.
Prudova A; auf dem Keller U; Butler GS; Overall CM
Mol Cell Proteomics; 2010 May; 9(5):894-911. PubMed ID: 20305284
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Langerhans cells.
Noirey N; Staquet MJ; Gariazzo MJ; Serres M; André C; Schmitt D; Vincent C
Eur J Cell Biol; 2002 Jul; 81(7):383-9. PubMed ID: 12160146
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.
Ramani VC; Kaushal GP; Haun RS
Biochim Biophys Acta; 2011 Aug; 1813(8):1525-31. PubMed ID: 21616098
[TBL] [Abstract][Full Text] [Related]
18. A subclass of soluble HLA-G1 modulates the release of cytokines from mononuclear cells present in the decidua additively to membrane-bound HLA-G1.
Kanai T; Fujii T; Kozuma S; Miki A; Yamashita T; Hyodo H; Unno N; Yoshida S; Taketani Y
J Reprod Immunol; 2003 Dec; 60(2):85-96. PubMed ID: 14638437
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Hum Reprod; 2013 Sep; 28(9):2407-16. PubMed ID: 23814095
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and -9: implications for chemotaxis.
Denney H; Clench MR; Woodroofe MN
Biochem Biophys Res Commun; 2009 May; 382(2):341-7. PubMed ID: 19281798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
